小儿脊柱侧凸手术中氨甲环酸的高剂量与低剂量前瞻性随机试验
本研究为前瞻性随机双盲试验,纳入166例10至21岁青少年特发性脊柱侧凸患者,比较 high-dose 与 low-dose 氨甲环酸在后路脊柱融合术中的效果。结果显示两组总手术失血量无显著差异,输血需求及不良事件亦无差异,低剂量氨甲环酸效果不劣于高剂量。
要点
- 高剂量与低剂量氨甲环酸组总手术失血量无显著差异。
- 两组输血需求及围手术期不良事件均无显著差异。
- 低剂量氨甲环酸在减少失血和输血方面与高剂量同样有效。
核心结论
- 低剂量氨甲环酸在减少青少年特发性脊柱侧凸后路脊柱融合术失血和同种异体输血方面与高剂量同样有效。
研究设计与样本
- 前瞻性随机双盲试验,纳入166例10至21岁青少年特发性脊柱侧凸患者,ASA I-II级,术前血红蛋白>10 g/dL,血小板计数>150,000 cells/L,Cobb角>45°,接受择期单阶段后路脊柱融合术。
主要发现
- 两组平均总手术失血量无显著差异(高剂量组:928.8 ± 406.1 mL,范围348-1857 mL;低剂量组:918.1 ± 406.2 mL,范围271-2000 mL,P = 0.865)。
- 手术时间中位数为120分钟。
- 每组各有一例患者在围手术期接受同种异体输血。
- 术前、术后0小时和48小时的血红蛋白及凝血功能无显著变化。
- 性别、融合椎体节段数和手术时间与总手术失血量独立相关。
关键数值与推荐
- 高剂量组:氨甲环酸负荷剂量30 mg/kg,随后10 mg/kg/h输注;低剂量组:负荷剂量10 mg/kg,随后1 mg/kg/h输注。
- 主要结局为两组总手术失血量,次要结局包括输血需求、围手术期血红蛋白和凝血功能变化、不良事件及影响总失血量的因素。
临床怎么用
- 对于青少年特发性脊柱侧凸后路脊柱融合术,可考虑使用低剂量氨甲环酸方案以减少失血和输血需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: Prospective randomized double-blinded trial. OBJECTIVE: The objective of this study is to determine the efficacy of high-dose versus low-dose tranexamic acid (TXA) in adolescent idiopathic scoliosis (AIS) corrective surgery. SUMMARY OF BACKGROUND DATA: Corrective surgery for AIS is associated with significant blood loss. Evidence on the optimum TXA dose to reduce bleeding in pediatric population is scarce. METHODS: A total of 166 AIS patients aged between 10 and 21 years, of American Society of Anesthesiologists (ASA) physical status I and II, preoperative hemoglobin >10 g/dL, platelet count >150,000 cells/L and Cobb angle of >45° scheduled for elective single-stage posterior spinal fusion (PSF) surgery by two attending surgeons were included between March 2017 and November 2018. Patients were randomized into Group A (High Dose, 30 mg/kg TXA loading dose followed by 10 mg/kg/h infusion) and Group B (Low Dose, 10 mg/kg TXA loading dose followed by 1 mg/kg/h infusion). The primary outcome was total surgical blood loss between both groups. Secondary outcomes were transfusion requirement, perioperative changes in hemoglobin and coagulation profiles, adverse events, and factors that influence total blood loss. RESULTS: The mean total surgical blood loss between the two groups was not significant (Group A: 928.8 ± 406.1 mL [range: 348-1857 mL]; Group B: 918.1 ± 406.2 mL [range: 271-2000 mL], P = 0.865). The median duration of surgery was 120 minutes. One patient in each group received allogenic blood transfusion during the perioperative period. There were no significant changes in hemoglobin and coagulation profile at pre-operation, post-operation 0 hour and 48 hours. Sex, number of vertebral levels fused, and duration of surgery were independently associated with total surgical blood loss. No adverse events were observed perioperatively. CONCLUSION: Low-dose TXA was as efficacious as high-dose TXA in reducing blood loss and allogenic blood transfusion for AIS patients undergoing PSF surgery.Level of Evidence: 1.
引用
- Hasan MS, Yunus SN, Ng CC, et al. Tranexamic Acid in Pediatric Scoliosis Surgery: A Prospective Randomized Trial Comparing High-dose and Low-dose Tranexamic Acid in Adolescent Idiopathic Scoliosis Undergoing Posterior Spinal Fusion Surgery. Spine (Phila Pa 1976). 2021. PMID: 33882541. doi:10.1097/BRS.0000000000004076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。